Overall rank by patents
#5,036
of 49,997 tracked assignees
USPTO PatentsView assignee record - 69 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).
The verdict
According to USPTO PatentsView, SEI ranks #5,036 of 49,997 tracked US assignees by granted-patent volume, with 69 patents across 16 technology areas.
USPTO PatentsView assignee plate
Corpus R5036 · Foreign Corporation #5,036 · 69 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Oura Health Oy (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Zhejiang Chint… · near
35 score
Hebei University OF… · near
35 score
SEI Optifrontier · this assignee
35 score
Aortic Innovations · near
35 score
HMD Global Oy · near
35 score
3D Lighting… · lowest
7 score
What this shows SEI's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
SEI Optifrontier Co., Ltd. is a focused PatentsView assignee: 16 CPC subclasses with 79.7% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2015 (15 grants) versus a trough of 1 in 2023. By volume, SEI sits between Oura Health Oy and Stealth BioTherapeutics Inc..
From 2019–2021 to 2022–2024, SEI Optifrontier Co., Ltd. moved from 22 to 5 grants (0.23x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Oura Health Oy
69 patents
PAX Labs, Inc.
69 patents
RFMicron, Inc.
69 patents
Rebellions Inc.
69 patents
Shinano Kenshi Kabushiki Kaisha
69 patents
Sanko Tekstil Isletmeleri San. Ve Tic. A.S.
69 patents
Sanofi Pasteur, Inc.
69 patents
Stealth BioTherapeutics Inc.
69 patents
SEI Optifrontier Co., Ltd.
69 patents
What this shows SEI holds 69 patents at rank #5,034, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #5,034 in granted patent volume.
Other assignees with the most granted patents in SEI's primary technology class.
Two PlainPatent-derived peer sets for SEI, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (35 here).
Nearest assignees by average claims per patent (7.4 here).
SEI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 15 | 21.7% |
| 2016 | 9 | 13.0% |
| 2017 | 4 | 5.8% |
| 2018 | 13 | 18.8% |
| 2019 | 6 | 8.7% |
| 2020 | 7 | 10.1% |
| 2021 | 9 | 13.0% |
| 2022 | 4 | 5.8% |
| 2023 | 1 | 1.4% |
| 2025partial year | 1 | 1.4% |
Top 15 of 16 technology areas
Overall rank by patents
#5,036
of 49,997 tracked assignees
34.8 out of 100
What to do with this data
SEI Optifrontier Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.